CrushSCI.com
提供学术论文选刊润色服务
Transplantation and Cellular Therapy 期刊封面 医学
返回期刊列表

Review Cycle Records

Transplantation and Cellular Therapy

Elsevier SCIE 非OA
2026新锐 2区2025中科院 3区2025 JCR Q1
76.7平均天数
56中位天数
14最短天数
238最长天数
1,1372025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

71 天

Real-World Assessment of Prophylactic Anakinra on Neurotoxicity and Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed and Refractory B-Cell Lymphoma: An Inverse Probability of Treatment Weighting Analysis

作者Neela Easton; Mia Andreoli; Herman van Besien; Caitlin Gribbin; Michelle Pasciolla; Anna Alperovich; Mateo Mejia Saldarriaga; Barbara Ma; Nora Chokr; Amer Assal; Joshua Fein; Sebastian Mayer; Alexandra Gomez Arteaga; Daniel Choi; Tsiporah Shore; Christopher S. Hackett; Juliet Barker; Samuel Yamshon

作者单位NewYork-Presbyterian/Weill Cornell, Hematology & Medical Oncology, New York, New York; NewYork-Presbyterian/Weill Cornell Medical Center, Medicine, New York, New York; Perlmutter Cancer Center, NYU Langone, New York, New York

PDF源文件 DOI 网页
55 天

Vaccine-Induced Anti-HBs Response is Associated with Protection Against Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Cell Transplantation: A Randomized Trial

作者Masahiro Onozawa; Shigeru Kusumoto; Yachiyo Kuwatsuka; Takayoshi Miyazono; Masatsugu Tanaka; Yuho Najima; Kohei Okada; Souichi Shiratori; Takayuki Sato; Junya Kanda; Yuichiro Inagaki; Tohru Murayama; Kaoru Hatano; Koichi Onodera; Masatoshi Sakurai; Shinya Endo; Takahiro Kumode; Hidehiro Itonaga; Yukiyoshi Moriuchi; Nobuhiro Kanemura; Tatsuya Imi; Taro Edahiro; Nobuaki Fukushima; Masahiro Oura; Shunsuke Yui; Mitsumasa Watanabe; Tomomi Toubai; Toshihiko Ando; Daisuke Nakamura; Masaharu Tamaki; Yasutaka Kakinoki; Takahiro Okada; Nobuaki Nakano; Takayoshi Tachibana; Hiroaki Shimizu; Shuichi Ota; Shinsuke Iida; Masaya Sugiyama; Yoshiko Atsuta; Takanori Teshima; Tomoharu Yoshizumi; Masashi Mizokami

作者单位Department of Hematology, Hokkaido University Hospital, Sapporo, Japan; Department of Hematology and Cell therapy, Aichi Cancer Center, Nagoya, Japan; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan; Department of Hematology, Imamura General Hospital, Kagoshima, Japan; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan; Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan; Department of Hematology, Graduate School of Medicine, Kyoto University Hospital, Kyoto, Japan; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan; Department of Hematology, Hyogo Cancer Center, Akashi, Japan; Department of Medicine, Division of Hematology, Jichi Medical University, Shimotsuke, Japan; Department of Hematology, Tohoku University Hospital, Sendai, Japan; Department of Medicine, Division of Hematology, Keio University School of Medicine, Tokyo, Japan; Department of Hematology, Rheumatology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan; Hematology and Rheumatology, Kindai University, Osaka, Japan; Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan; Department of Hematology, Sasebo City General Hospital, Sasebo, Japan; Department of Hematology & Infectious Disease, Gifu University Hospital Gifu, Japan; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan; Department of Hematology and Oncology, Konan Kosei Hospital, Konan, Japan; Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan; Department of Hematology, Nippon Medical School, Tokyo, Japan; Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan; Department of Hematology and Cell Therapy, Yamagata University Hospital, Yamagata, Japan; Department of Internal Medicine, Division of Hematology, Respiratory Medicine and Oncology, Faculty of Medicine, Saga University, Saga, Japan; Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan; Department of Hematology, Shimane University Hospital, Izumo, Japan; Department of Viral Pathogenesis and Controls, National Institute of Global Health and Medicine, Japan Institute for Health Security, Kohnodai, Japan; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Genome Medical Sciences Project, National Institute of Global Health and Medicine, Japan Institute for Health Security, Konodai, Japan; Molecular and Cellular Glycoproteomics Research Group, Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan

PDF源文件 DOI 网页
50 天

Consolidation Therapy with Checkpoint Inhibitors After Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Multiple Myeloma and Lymphoma

作者Lindsay Fogel; Patrick C. Roney; Jaeil Ahn; Joshua Zenreich; Adolfo Aleman; Kimberly Doucette; Palka Anand; Andrew Ip; Andre Goy; Tatyana Feldman; Lori Leslie; Andrew Pecora; Pooja Phull; Harsh Parmar; David Vesole; David S. Siegel; Noa Biran

作者单位Hackensack Meridian School of Medicine, Nutley, New Jersey; Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey

PDF源文件 DOI 网页
44 天

Long-Term Gynecologic and Reproductive Health in Female Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-analysis of Prevalence

作者Muhammad Kashif Amin; Nabeeha Noor; Muhammad Talha Maqsood; Hameer Ali; Hateem Ahmad; Huda Memon; Fatima Iqbal; Saniya Ishtiaq; Mahad Zamir; Momin Shaukat; Alma Habib; Moazzam Shahzad; Mehdi Hamadani; Joseph McGuirk; Muhammad Umair Mushtaq

作者单位Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas; The Mikael Rayaan Foundation Global Research Training Institute (MRF GRTI), Kansas City, Kansas; U.S. Myeloma Innovations Research Collaborative, Kansas City, Kansas; Division of Hematology and Oncology, Moffitt Cancer Center, University of South Florida, Tampa, Florida; Medical College of Wisconsin, Milwaukee, Wisconsin

PDF源文件 DOI 网页
101 天

Cord Blood Transplantation versus Other Donor Sources in High-Risk Acute Myeloid Leukemia

作者Tatsuro Hirao; Hisashi Yamamoto; Mika Kuno; Otoya Watanabe; Kyosuke Yamaguchi; Kosei Kageyama; Daisuke Kaji; Yuki Taya; Aya Nishida; Shinsuke Takagi; Yuki Asano-Mori; Go Yamamoto; Atsushi Wake; Shuichi Taniguchi; Naoyuki Uchida

作者单位Department of Hematology, Toranomon Hospital, Tokyo, Japan; Centre for Long-Term Follow-Up After Hematopoietic Cell Transplantation, Toranomon Hospital, Tokyo, Japan; Okinaka Memorial Institute for Medical Research, Tokyo, Japan; Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan; Department of Transfusion and Cellular Therapy, Toranomon Hospital, Tokyo, Japan; Centre for Cellular Therapy, Toranomon Hospital, Tokyo, Japan

PDF源文件 DOI 网页
48 天

Association of MRD Status With Survival Outcomes and Cytokine Release Syndrome in Outpatient Transplantation After Reduced-Intensity Conditioning for Acute Lymphoblastic Leukemia: Experience From a Low- and Middle-Income Country Reference Center

作者José Carlos Jaime-Pérez; Alberto Villalón-López; Nereida Méndez-Ramírez; Rosario Salazar-Riojas; César Homero Gutiérrez-Aguirre; Olga Graciela Cantú-Rodríguez; David Gómez-Almaguer

作者单位Hematology Department, Internal Medicine Division, Dr. José Eleuterio González University Hospital and School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Mexico

PDF源文件 DOI 网页
89 天

Excellent Long-Term Survival and Immune Recovery With Reduced-Intensity Conditioning HCT in Inborn Errors of Immunity

作者Hannah Lust; Olatundun Williams; Jennifer Schneiderman; Reggie Duerst; David Jacobsohn; Angelo Rivera; Ramsay Fuleihan; William T. Tse; Morris Kletzel; Sonali Chaudhury

作者单位Division of Hematology/Oncology/Stem Cell Transplantation, Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Clinical Research Division, Fred Hutchinson Cancer Center and Department of Pediatrics, University of Washington, Seattle, Washington; Department of Pediatrics at George Washington University, Children’s National Hospital, Washington, District of Columbia; Mathews Center for Cellular Therapy, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Division of Allergy & Immunology, Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Division of Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky. Deceased.

PDF源文件 DOI 网页
14 天

Step-Specific Activation Timelines for Cellular Therapy Clinical Trials: A Decade of Regulatory Improvement and Persistent Financial Bottlenecks

作者Joseph Farinella; Stephanie Farlow; Claudio Brunstein; Paolo F. Caimi

作者单位Bone Marrow and Cellular Therapy Program, Cleveland Clinic Cancer Institute, Cleveland, Ohio; Case Comprehensive Cancer Center, Cleveland, Ohio

PDF源文件 DOI 网页
57 天

Donor Source Selection in Hematopoietic Cell Transplantation: Practices and Perceptions Across 50 United States Transplant Centers

作者Jaime M. Preussler; Jill Randall; Christa Meyer; Kim Wadsworth; Kelley Frederick; Traci Sutter; Paris McGhee; Ellen Denzen; Anna M. DeSalvo

作者单位CIBMTR® (Center for International Blood and Marrow Transplant Research) NMDP, Minneapolis, Minnesota; NMDP, Minneapolis, Minnesota

PDF源文件 DOI 网页
238 天

Increased Susceptibility to Long-Term Complications in Leukemia Survivors Who Received Hematopoietic Stem Cell Transplantation During Adolescence

作者Léna Pessarossi; Marilyne Poirée; Jean-Hugues Dalle; Sandrine Visentin; Carine Domenech; Cécile Renard; Cécile Pochon; André Baruchel; Mony Fahd; Virginie Gandemer; Charlotte Jubert; Stéphane Ducassou; Catherine Paillard; Laura Olivier-Gougenheim; Alexandre Theron; Dominique Plantaz; Marie-Dominique Tabone; Guy Leverger; Justyna Kanold; Sandrine Thouvenin-Doulet; Zeinab Hamidou; Mohamed Boucekine; Julie Berbis; Pascal Auquier; Gérard Michel; Paul Saultier

作者单位Department of Pediatric Hematology, Immunology and Oncology, La Timone Children’s Hospital, Marseille, France; Pediatric Hematology and Oncology Department, University Hospital L’Archet, Nice, France; Hematology and Immunology Department, Robert Debré Hospital, GHU APHP Nord, Université de Paris, Paris, France; Department of Pediatric Hematology, Immunology and Oncology, Aix Marseille Univ, APHM, CERESS, La Timone Children’s Hospital, Marseille, France; Department of Pediatric Hematology and Oncology, IHOP, Hospices Civils de Lyon, Lyon 1 University, Lyon, France; Department of Pediatric Onco-Hematology, Hôpital d’Enfants de Brabois, Vandoeuvre Les Nancy, France; Department of Pediatric Hematology and Oncology, University Hospital of Rennes, Rennes, France; Department of Pediatric Hematology and Oncology, University Hospital of Bordeaux, Bordeaux, France; Department of Pediatric Hematology-oncology, University Hospital, Strasbourg, France; Department of Pediatric Hematology and Oncology, University Hospital of Toulouse, Toulouse, France; Department of Pediatric Hematology and Oncology, University Hospital, Montpellier, France; Department of Pediatric Hematology-Oncology, University Hospital of Grenoble, Grenoble, France; Department of Pediatric Hematology, Immunology and Oncology, Armand Trousseau Hospital, Sorbonne University, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, France; Department of Pediatric Hematology and Oncology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France; Department of Pediatric Hematology-Oncology, University Hospital St Etienne, St Etienne, France; Department of Public Health, Aix Marseille Univ, APHM, CERESS, Marseille, France; Department of Pediatric Hematology, Immunology and Oncology, Aix Marseille Univ, APHM, INSERM, INRAE, C2VN, La Timone Children’s Hospital, Marseille, France

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。